University of Cambridge completes first human trial of an AI-designed vaccine targeting all coronaviruses, showing safety and immune responses in 39

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…

De University of Cambridge in het Verenigd Koninkrijk heeft met behulp van kunstmatige intelligentie (AI) een manier gevonden om nieuwe vaccins te ontwikkelen. Daarmee kan snel…

De University of Cambridge in het Verenigd Koninkrijk heeft met behulp van kunstmatige intelligentie (AI) een manier gevonden om nieuwe vaccins te ontwikkelen. Daarmee kan snel…

Researchers at the University of Cambridge have developed the first-ever vaccine component designed entirely by artificial intelligence, now trialled in humans.

Sono già buoni i risultati della sperimentazione di fase 1: a realizzarlo l'Università di Cambridge

A new AI-designed vaccine capable of protecting against entire families of viruses could transform how the world prepares for a future pandemic.

AI-designed ‘super-antigen’ vaccine passes first human trial, raising hopes for future-proof protection against coronavirus families and emerging pandemics.

A vaccine designed with the help of artificial intelligence has entered human trials in what scientists are calling a world-first moment for medical research and drug development.

A groundbreaking vaccine, designed entirely by artificial intelligence, has been tested in humans for the first time. This experimental jab aims to protect against a wide range of…

Lo studio dell'Università di Cambridge punta a sviluppare vaccini universali contro coronavirus, influenza ed Ebola, con l'obiettivo di prevenire future pandem…

Vaccino universale progettato con IA supera primi test clinici: protegge da Covid, Ebola e virus futuri. Scopri come Cambridge anticipa le pandemie con l'intelligenza artificiale.

Cambridge scientists have successfully completed the first human trial of an AI-designed universal coronavirus vaccine, aiming to protect against future pa

pEVAC-PS is the first experimental vaccine designed completely with AI to be tested in a human trial.

The experimental jab is intended to target a wide range of viruses, including those behind deadly outbreaks like Sars, Mers and Covid-19.

Científicos de Cambridge afirman que ayudaría a proteger contra una variedad de virus y prevenir futuras pandemias

Cientistas de Cambridge dizem ter testado pela primeira vez em pessoas uma vacina projetada por IA

Targets entire family of viruses, animal-borne strains; aims to thwart future pandemics; initial-phase trials of 39 participants succeeded; larger efficacy studies loom.

University of Cambridge completes first human trial of an AI-designed vaccine targeting all coronaviruses, showing safety and immune responses in 39

Investigadores de Cambridge y DIOSynVax probaron la vacuna en 39 voluntarios sanos en el Reino Unido

University of Cambridge completes first human trial of an AI-designed vaccine, showing safety and broad immune response against multiple coronaviruses in 39